| Abstract P052 – Table 1. Baseline characteristics. | |||
|---|---|---|---|
| Baseline characteristics | BIC/FTC/TAF (n=95) | Other ART options (n=137) | p‐value |
| Gender: Women, n (5) | 12 (12.6) | 21 (15.3) | 0.563 |
| Age (yrs), median (IQR) | 39.9 (31.7 ‐ 48.1) | 39.6 (32.8 ‐ 49.0) | 0.532 |
| Way of transmission, n (%) | |||
| Homosexual | 52 (54.7) | 75 (55.5) | 0.088 |
| Heterosexual | 39 (41.1) | 43 (31.4) | |
| Intravenous drug use | 1(1) | 2 (1.4) | |
| Unknown | 3 (3.2) | 16 (11.7) | |
| Country of born, n (%) | |||
| Spain | 45 (47.4) | 67 (48.9) | 0.818 |
| Other | 50 (52.6) | 70 (51.1) | |
| AIDS diagnosis, n (%) | 35 (36.8) | 49 (35.8) | 0.867 |
| CD4 nadir, n (%) | 103 (53 ‐ 162) | 92 (47 ‐ 167) | 0.566 |
| CD4 nadir <59 cel/mm3, n (%) | 22 (23.2) | 33 (24.1) | 0.142 |
| HIV RNA >10⁵ cop/mL | 61 (64.2) | 85 (62.0) | 0.639 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.